Skip to content

Moderna MRNA Cambridge Massachusetts — Operating Leases Rent Expense Minimum Rentals

Discontinued — last reported Q3 '15

Similar metrics at other companies

Equity Residential logo
EQRBoston — Operating Lease Lease Income
$81.08M+1.7%
News Corporation logo
NWSAOperating Lease Expense
$17M-5.6%
Texas Roadhouse logo
TXRHRent And Lease Expense Included In Cost Of Revenue
$24.71M+9.9%
SSD
SSDOperating Lease Expense
$4.91M+15.6%
Henry Schein logo
HSICOperating Lease Cost Total
$28.75M-11.5%
Kimco Realty logo
KIMReal Estate Rental Operations — Operating Expenses Rent
$4.15M-0.9%

Other financials

Income statement

See full
Revenue$389.0M+260%
Gross profit-$566.0M-3,244%
Operating income-$1.4B-32.2%
Net income-$1.3B-38.3%
EPS (diluted)-$3.40-34.9%

Balance sheet

See full
Cash & equivalents$1.9B+17.4%
Total debt$1.3B+71.9%
Total equity$7.4B-26.4%
Total assets$11.5B-9.6%

Cash flow

See full
Operating cash flow-$630.0M+39.2%
CapEx$62.0M-47.0%
Free cash flow-$692.0M+40.0%

Valuation

See full
Market cap$25.38B+83.8%
Enterprise value$24.8B+93.6%
P/S11.4×+7.1×

Profitability

See full
Gross margin22.1%-32.0pp
Operating margin-153.3%+67.8pp
Net margin-143.6%+80.2pp
FCF margin-132.4%

Returns & leverage

See full
Return on equity-36.6%+11.9pp
Debt / equity0.2×+0.1×
Current ratio2.4×-1.8×

Where this comes from

Reported directly by Moderna in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeasesRentExpenseMinimumRentals.

The official record: Moderna’s 10-K, filed February 27, 2020, on SEC EDGAR. View the filing →

Questions, answered.

What does cambridge massachusetts — operating leases rent expense minimum rentals mean?
This metric represents the fixed, non-cancellable minimum rental payments required under operating lease agreements for real estate facilities located in the Cambridge, Massachusetts hub. It reflects the baseline recurring cash outflow commitment for the company's primary research and corporate headquarters infrastructure. Monitoring this helps assess the fixed overhead burden associated with maintaining a significant physical footprint in a high-cost biotech cluster.